We found that the incidence of mutations in the KRAS gene was related to gender, depth of invasion, and TNM stage in CRC, but not related to age, lymph node metastasis, tumor location, tumor differentiation, or mucous adenocarcinoma. This evidence concerns the gene KRAS and metastatic malignant neoplasm in the lymph nodes.